Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19. (October 2020)

• Record Type: Journal Article
• Authors: Buschard, Karsten
• Is Part Of: Medical hypotheses. Volume 143(2020)
• Publication Date: 2020-10
• Subjects: Corona virus -- Fenofibrate -- Sphingolipids -- Sulfatide -- Serine; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Medicine; Periodicals; 610
• DOI: 10.1016/j.mehy.2020.110127
• Languages: English
• ISSNs: 0306-9877

Abstract

Abstract: Fenofibrate, which is a PPAR-alfpha agonist, increases the level of sulfatide. In this letter we hypothesize on the background of various findings that this is beneficial against COVID-19. Fenofibrate has been used for decades against hypercholesterolemia and has no serious side effects. Therefore, a trial giving fenofibrate to patients with corona virus infection is recommended.